December 4
Complex cases demand more than one perspective. Dermatology, oncology, and surgery come together here to chart the best path forward. How do you define risk? When is the right time to integrate IO? What role should each specialty play?
On Thursday, December 4, join dermatology, oncology, and surgery experts for a live, complimentary virtual summit dedicated exclusively to the complex challenges of high-risk CSCC. Through case-driven discussions and tumor board–style collaboration, faculty will unpack how to stage, stratify, and select the best treatment pathways—together.
You’ll examine referral triggers, explore multidisciplinary models of care, and learn how adjuvant and neoadjuvant immunotherapy strategies are reshaping perioperative planning. Most importantly, you’ll see how a united approach translates into smarter, stronger outcomes for patients.
This is more than theory—it’s decision-making in action. Don’t miss the opportunity to step inside the conversation and bring fresh perspective back to your practice.
Details:
(This event is non-accredited.)
Gain the insights you need to navigate staging, sequencing, and immunotherapy integration—while discovering how collaboration across disciplines is shaping the next era of treatment.
This live virtual summit is designed for healthcare professionals involved in the management of high-risk cutaneous squamous cell carcinoma (CSCC), including: